Multicenter AIDS Cohort Study (MACS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00046280|
Recruitment Status : Unknown
Verified July 2019 by National Institute of Allergy and Infectious Diseases (NIAID).
Recruitment status was: Active, not recruiting
First Posted : September 26, 2002
Last Update Posted : July 18, 2019
|Condition or disease|
The Multicenter AIDS Cohort Study (MACS) provides important information about the changing nature of HIV-mediated disease progression, the impact of antiretroviral treatment, the nature of HIV pathogenesis, and viral and host genetic factors. This study will also assess the long-term patterns of therapy use and risk-taking behaviors.
Patients will have study visits every 6 months. The visits will include interviews, specimen collection, and a physical examination.
|Study Type :||Observational|
|Estimated Enrollment :||7087 participants|
|Official Title:||Multicenter AIDS Cohort Study (MACS)|
|Study Start Date :||April 1984|
|Estimated Primary Completion Date :||April 30, 2020|
|Estimated Study Completion Date :||April 30, 2020|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00046280
|United States, California|
|Public Health Center|
|Los Angeles, California, United States|
|United States, Illinois|
|CORE Health Center|
|Chicago, Illinois, United States|
|United States, Maryland|
|Johns Hopkins School of Public Health|
|Baltimore, Maryland, United States|
|United States, Pennsylvania|
|University of Pittsburgh School of Public Health|
|Pittsburgh, Pennsylvania, United States|